COMPANY PROFILE / #2906
Darmiyan
Half Moon Bay, CAVenture Capital-Backed
OVERVIEW
Developer of a brain imaging technology designed to offer early detection, visualization and quantification of neurodegenerative disorders. The company's platform offers inputs from human brain MRI and produces maps that detect diseases before their symptoms show up, enabling healthcare providers to assist patients who suffer from brain diseases to be diagnosed early and get cured.
已融资10.89
最新估值52.00
员工数23
成立年份2016
公司概况
- Companies
- Darmiyan
- Description
- Developer of a brain imaging technology designed to offer early detection, visualization and quantification of neurodegenerative disorders. The company's platform offers inputs from human brain MRI and produces maps that detect diseases before their symptoms show up, enabling healthcare providers to assist patients who suffer from brain diseases to be diagnosed early and get cured.
- Website
- www.darmiyan.com
- HQ Location
- Half Moon Bay, CA
- Year Founded
- 2016
- Keywords
- alzheimer treatment, brain health monitor, brain imaging, brain imaging software, brain imaging technology, detection technology, neurological treatment
- Competitors
- Optina Diagnostics, WinterLight Labs
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 10.89
- First Financing Date
- 11-Jul-2017
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 17-Oct-2023
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 3.54
- Last Financing Valuation
- 52.00
- Last Financing Status
- Completed
- Last Known Valuation
- 52.00
- Last Known Valuation Date
- 17-Oct-2023
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 69.50
- Valuation Estimate Growth Rate
- 33.65%
- Active Investors
- AAF Management, Amgen, Arkitekt Ventures, Berkeley SkyDeck, CABHI, Cameron Bahar, Camford Capital, DHVC, Eisai, Eisai Innovation, Evan Cheng, Golden Egg Ventures, Hamid Moghadam, Hanmi Pharm, IT-Farm, MedTech Innovator, Openner, QB3, Seed Group, Seven Seas Partners, Soma Capital, SOMPO., UpHonest Capital, Wei Guo, Y Combinator
- # Active Investors
- 25
- Acquirers
- —
团队与联系人
- Employees
- 23
- Employee Growth %
- 9.52%
- Employee History
- 2026: 23, 2025: 21, 2024: 22, 2023: 19 E, 2022: 16, 2021: 15, 2020: 11, 2019: 9 E, 2018: 8 E, 2017: 6
- Primary Contact
- Padideh Kamali-Zare
- Primary Contact Title
- Co-Founder, Chief Executive Officer, President & Chairperson
- Primary Contact Email
- padideh@darmiyan.com
- Primary Contact Phone
- +1 (917) 689-0389
增长与经营
- Revenue
- 1.60
- Revenue Growth %
- 60.00%
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 0.05x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 2
- Majestic Referring Domains
- 220
- SimilarWeb Unique Visitors
- 15
- SimilarWeb Unique Visitors Change
- -40
- SimilarWeb Growth Rate
- 0.00%
- SimilarWeb Growth Rate Percentile
- 9
- Success Probability Over Time – 1 Year
- 5%
- Success Probability Over Time – 3 Year
- 23%
- Success Probability Over Time – 5 Year
- 30%
记录来源：public.companies · 原始序号 #2906 · 所有字段均按数据库原值展示。